KCP
BIIB icon

Kera Capital Partners’s Biogen BIIB Stock Holding History

Kera Capital Partners’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$383K Buy
1,772
+49
+3% +$9.37K 0.04% 405
2026
Q1 		$316K Buy
1,723
+58
+3% +$10.7K 0.04% 392
2025
Q4 		$300K Hold
1,665
– – 0.04% 403
2025
Q3 		$233K Buy
+1,665
New +$225K 0.04% 368

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Kera Capital Partners's BIIB Position: Q2 2026 in Review

Kera Capital Partners increased its Biogen (BIIB) stake by 2.8% in Q2 2026, buying an estimated $9.37K and bringing the position to 1,772 shares worth $383K. The position accounts for 0.04% of the portfolio, ranked #405.

Kera Capital Partners first reported a position in BIIB in Q3 2025 and has held it in 4 quarters since. 1,038 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Kera Capital Partners held 1,772 shares of Biogen worth $383K as of Q2 2026.
  • Kera Capital Partners bought 49 Biogen shares in Q2 2026, an estimated $9.37K.
  • Biogen made up 0.04% of Kera Capital Partners's portfolio in Q2 2026, its #405 holding.
  • Kera Capital Partners first reported a position in Biogen in Q3 2025 and has held it in 4 quarters since.
  • 1,038 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Kera Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.